What is CLYM's dilution risk score?

CLYM currently has a DilutionScore of 52/100, indicating high dilution risk. DilutionWatch monitors CLYM SEC filings in real-time, scanning EDGAR every 60 seconds for shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals.

What SEC filings does DilutionWatch track for CLYM?

DilutionWatch tracks 25 SEC filing types for CLYM including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect CLYM shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For CLYM, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for CLYM tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for CLYM. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

CLYM Dilution Risk Score: 52/100 (HIGH)

📊 Score Breakdown

📋 Offering Ability

52

💰 Cash Runway

10

📊 Float Risk

60

⚠️ Warrant Exposure

90

🔄Convertible Debt—

🌦️ Dilution Forecast

⛈️

Warning

High probability of dilution event

30%

📜 Warrant Exercise 60%

• Massive warrant overhang: 39% of shares outstanding

• Warrant risk score very high (90/100)

🔔 Track CLYM — Get forecast alerts →

💹 Market Data

Market Cap$627.58M

Shares Outstanding57.26M

Float28.06M

Cash$109.56M

Debt$479.0K

Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 1.4% shares (2026Q1 vs prior)

83 institutional holders · 34.41M shares

#1 RA CAPITAL MANAGEMENT, L.P. 11.30M shares

#2 MPM BIOIMPACT LLC 2.59M shares

#3 VANGUARD CAPITAL MANAGEMENT LLC 2.36M shares

+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest5.10M

Days to Cover3.0

% of Float18.2%

FINRA data as of Jun 30, 2026

👤 Insider Buy/Sell Ratio

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2021

8-K 8K EVENT Apr 28, 2026

4 INSIDER TRANSACTION Feb 27, 2026

4 INSIDER TRANSACTION Feb 17, 2026

4 INSIDER TRANSACTION Jan 08, 2026

Full SEC filing analysis available with free account →

📰 Recent News

No recent news

📋 What This Means for CLYM Shareholders

Climb Bio, Inc. (CLYM) has a DilutionScore of 52/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 14, 2026, updated from SEC EDGAR data.

DilutionWatch tracks 22.5M outstanding warrants for CLYM. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window.

DilutionWatch tracks over 25 SEC filing types for CLYM in real-time, scanning EDGAR every 60 seconds. Recent 8-K filings are present; material events disclosures can sometimes precede or accompany capital raises. The DilutionWatch screener shows real-time score changes for CLYM alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

Warrants Explained →